86R14038 LHC-D
By: Johnson of Harris H.B. No. 2576
A BILL TO BE ENTITLED
AN ACT
relating to prescribing and dispensing certain controlled
substances to patients diagnosed with sickle cell anemia.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Sections 481.0765(a) and (b), Health and Safety
Code, are amended to read as follows:
(a) A prescriber is not subject to the requirements of
Section 481.0764(a) if:
(1) the patient has been diagnosed with cancer or
sickle cell anemia or the patient is receiving hospice care; and
(2) the prescriber clearly notes in the prescription
record that the patient was diagnosed with cancer or sickle cell
anemia or is receiving hospice care, as applicable.
(b) A dispenser is not subject to the requirements of
Section 481.0764(a) if it is clearly noted in the prescription
record that the patient has been diagnosed with cancer or sickle
cell anemia or is receiving hospice care.
SECTION 2. The change in law made by this Act applies only
to a prescription issued on or after the effective date of this Act.
A prescription issued before the effective date of this Act is
governed by the law in effect on the date the prescription is
issued, and the former law is continued in effect for that purpose.
SECTION 3. This Act takes effect September 1, 2019.